Build status - In Progress

CART-38 in Adult AML and MM Patients - 1

Investigating an Investigational Treatment for Adult Acute Myeloid Leukemia and Multiple Myeloma

Enrolling By Invitation
99 years or below
All
Phase N/A
1 Location

Brief description of study

TX Study See protocol section 2 See protocol section 2 See protocol section 4

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Medical Research
  • Age: 99 years or below
  • Gender: All

TBD

This study investigates the use of CART-38 in adults with acute myeloid leukemia (AML) and multiple myeloma (MM).

The aim is to evaluate the effects of CART-38 on these conditions. Researchers are looking at how well this treatment works and its safety for patients.

  • Who can participate: Participants must be adults aged 18 years and older diagnosed with acute myeloid leukemia or multiple myeloma.
  • Study details: Participants will receive the investigational treatment. The study will monitor the effects and safety of this investigational treatment.
Updated on 01 Jul 2025. Study ID: 169278443
If you need assistance finding a non-cancer clinical research study or if you have any questions, please email psom-ocr@pobox.upenn.edu For Cancer trials contact Penn Medicine's Cancer Trial Navigator at: PMCancerResearch@pennmedicine.upenn.edu or 215-349-8245

Study is selecting its participants from a population, or group of people, decided on by the researchers in advance.

Contact Abramson Cancer Center Navigator